Please assess the completion status of the following clinical trial:

Trial Title: Follow-up Gun Study: Can Safety Videos Mitigate Interest in Guns in Children?

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Age 8-12 yrs~* No prior participation in the study~* Able to schedule participation with a known peer (8-12yo).~Exclusion Criteria:~* Younger than 8 yrs old~* Older than 12 yrs old~* Prior study participation~* Could not schedule participation with a known peer (8-12yo)

- Gender: ALL
- Minimum Age: 8 Years
- Maximum Age: 12 Years
- Healthy Volunteers: t

Study Arms:
- Gun safety vid x Movie clip - guns present (Type: EXPERIMENTAL): Participants in this condition will view a gun safety video featuring The Ohio State University Chief of Police about a week before coming into the lab. In the lab, they will watch a \~20 minute clip of either The Rocketeer or National Treasure featuring guns.
- Gun safety vid x Movie clip - guns absent (Type: ACTIVE_COMPARATOR): Participants in this condition will view a gun safety video featuring The Ohio State University Chief of Police about a week before coming into the lab. In the lab, they will watch a \~20 minute clip of either The Rocketeer or National Treasure with the guns edited out.
- Seatbelt safety video x Movie clip - guns present (Type: ACTIVE_COMPARATOR): Participants in this condition will view a seatbelt safety video about a week before coming into the lab. In the lab, they will watch a \~20 minute clip of either The Rocketeer or National Treasure featuring guns.
- Seatbelt safety video x Movie clip - guns absent (Type: ACTIVE_COMPARATOR): Participants in this condition will view a seatbelt safety video about a week before coming into the lab. In the lab, they will watch a \~20 minute clip of either The Rocketeer or National Treasure featuring guns.

Based on this trial design, predict the completion outcome and termination type (if applicable).